ArticleThe Eurasian journal of medicine2026
Seropositivity Status in Patients with Suspected Measles: Are We Going Back to The Beginning with Measles?
Article in The Eurasian journal of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMeasles is a highly contagious viral infection that can cause serious health problems. While measles can be eradicated through vaccination in our country and worldwide, in recent years, vaccine refusal, difficulties in accessing vaccines during the coronavirus disease 2019 (COVID-19) pandemic, and insufficient immunity in young adults have brought the "measles virus" back into the spotlight. The aim of this study was to compare ELISA results for measles IgM and IgG in samples from patients examined at our hospital in in 2024 who were suspected of having measles, with respect to variables such as age, gender, and season.
methodsIn serum samples taken from patients with suspected measles who came to Kars Kafkas University Faculty of Medicine Medical Microbiology Laboratory, Measles IgG, measles IgM tests (Anti-Measles Virus IgM, Anti-Measles Virus IgG) were studied with kits of the same device in the Enzyme-Linked Immunosorbent Assay (ELISA) method, and the results were evaluated in line with the manufacturer's recommendations.
resultsIn our study, 30 (63.8%) of 47 patients tested were seropositive for measles IgG antibodies. Measles IgM antibodies were detected in 2 (4.3%) of the 47 patients tested. One patient had intermediate values for both measles IgG and IgM.
conclusionIn our study, no significant relationships were found between age, gender, and season and the Measles IgG and IgM tests. In our study, 34% of the patients in Kars province with measles antibody responses were found to be susceptible to measles infection. Cite this article as: Balkan Bozlak ÇE, Uçar M, Çelebi ., Yılmaz A. Seropositivity status in patients with suspected measles: are we going back to the beginning with measles? 2026, 58(3), 1203, doi: 10.5152/eurasianjmed.2026.251181.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.